Business
Preliminary results for the year to 31 March 2014
Preliminary results for the year to 31 March 2014.
About this update from Rua Life Sciences Plc
[{"type":"text","content":"\n \nRNS Number : 3249P AorTech International PLC 18 August 2014 \n\nAorTech International plc\n(\"AorTech\", \"the Company\" or \"the Group\")\n \nPreliminary audited results for the year ended 31 March 2014\n \n \nAorTech International plc (AIM: AOR), the biomaterials and medical device IP company, today announces its preliminary results for the year ended 31 March 2014.\n \n \nFinancial summary\n· Group revenue from continuing operations US$0.4m (2013 US$0.3m)\n· Operating loss from continuing operations US$764k (2013: US$1,205k loss from continuing operations)\n· Cash reserves decreased from US$987k to US$642k\n \nOther developments\n· Business completed transition to exploiting its IP and outsourcing its polymer manufacture\n· Significantly lower cost base going forward, following exit from US\n· Board restructured following exit of former CEO\n \n \n \n \n \nFor further information contact:\n \nAorTech International plc \nEddie McDaid, Chief Executive Tel: +44 (0)7802 920869 \n \nAorTech International plc \nBill Brown, Chairman Tel: +44 20 3206 7335 \n \nfinnCap Limited\nStuart Andrews / James Thompson Tel: +44 20 7220 0500 \n \n \n \nA copy of this announcement will be available at aortech.com/investor/announcements. The content of the website referred to in this a...